The value of anti-Saccharomyces cerevisiae antibodies (ASCA) as subclinical marker in Crohn's disease (CD).

被引：0
|
作者：
Vermeire, S
Peeters, M
Joossens, S
Dantonio, R
Bossuyt, L
Sendid, B
Poulain, D
Colombel, JF
Rutgeerts, P
机构：
[1] UZ Leuven, Louvain, Belgium
[2] CHU Lille, F-59037 Lille, France
[3] Hosp Claude Huriez, Lille, France
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3647
引用
收藏
页码：A839 / A839
页数：1
相关论文
共 50 条
  • [21] Synergism of NOD2 and ASCA (anti-saccharomyces cerevisiae antibodies) contributes to disease behavior in pediatric Crohn's disease (CD) patients
    Dubinsky, MC
    Lee-Uy, N
    Lin, YC
    Dutridge, D
    Vasiliauskas, EA
    Landers, CJ
    Targan, SR
    Roundtree, B
    Thomas, D
    Davis, J
    Dallalzadeh, S
    Bahar, R
    Taylor, KD
    Rotter, JI
    Yang, HY
    GASTROENTEROLOGY, 2003, 124 (04) : A372 - A372
  • [22] Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies:: a reassessment
    Aydin, S. Z.
    Atagunduz, P.
    Temel, M.
    Bicakcigil, M.
    Tasan, D.
    Direskeneli, H.
    RHEUMATOLOGY, 2008, 47 (02) : 142 - 144
  • [23] Targeting Tissular Immune Response Improves Diagnostic Performance of Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn's Disease
    Bertin, Daniel
    Grimaud, Jean-Charles
    Lesavre, Nathalie
    Benelmouloud, Chahine
    Desjeux, Ariadne
    Garcia, Stephane
    Desplat-Jego, Sophie
    PLOS ONE, 2013, 8 (11):
  • [24] Anti Saccharomyces cerevisiae mannan antibodies (ASCA) in healthy relatives of patients with Crohn's disease (CD)
    Sendid, B
    Quinton, JF
    Charrier, G
    Cortot, A
    Grandbastien, B
    Poulain, D
    Colombel, JF
    GUT, 1997, 41 : A177 - A177
  • [25] Anti-Saccharomyces cerevisiae antibodies (ASCA) combined with anti neutrophil antibodies (ANCA) differentiate Crohn's disease from ulcerative colitis.
    Quinton, JF
    Sendid, B
    Reumaux, D
    Cortot, A
    Poulain, D
    Colombel, JF
    GASTROENTEROLOGY, 1997, 112 (04) : A1066 - A1066
  • [26] PREVALENCE OF ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES IN BULGARIAN PATIENTS WITH CROHN'S DISEASE
    Mitev, Stefan
    Petkova, Mariya
    Velikova, Tsvetelina
    Ivanova-Todorova, Ekaterina
    Shentova, Rayna
    Yaneva, Penka
    Ivanova, Radina
    Panteleeva, Emilia
    Zhelev, Christo
    Kyurkchiev, Dobroslav
    Spassova, Zoya
    Mateva, Lyudmila
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2017, 70 (02): : 289 - 294
  • [27] Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S-cerevisiae in this setting
    Sendid, B.
    Jawhara, S.
    Sarter, H.
    Maboudou, P.
    Thierny, C.
    Gower-Rousseau, C.
    Colombel, J. F.
    Poulain, D.
    VIRULENCE, 2018, 9 (01) : 1224 - 1229
  • [28] Anti-Saccharomyces cerevisiae antibodies and response to infliximab in refractory Crohn's disease
    Schröder, O
    Naumann, M
    Stein, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (07) : 823 - 824
  • [29] Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis
    Andretta, Marianne A.
    Vieira, Thais D.
    Nishiara, Renato
    Skare, Thelma L.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) : 551 - 554
  • [30] Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
    Muratori, P
    Muratori, L
    Guidi, M
    Maccariello, S
    Pappas, G
    Ferrari, R
    Gionchetti, P
    Campieri, M
    Bianchi, FB
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (03): : 473 - 476
12345